Hideharu Hagiya

4.0k total citations
307 papers, 2.2k citations indexed

About

Hideharu Hagiya is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Hideharu Hagiya has authored 307 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Epidemiology, 104 papers in Infectious Diseases and 47 papers in Surgery. Recurrent topics in Hideharu Hagiya's work include Antibiotic Resistance in Bacteria (33 papers), Streptococcal Infections and Treatments (33 papers) and Antimicrobial Resistance in Staphylococcus (28 papers). Hideharu Hagiya is often cited by papers focused on Antibiotic Resistance in Bacteria (33 papers), Streptococcal Infections and Treatments (33 papers) and Antimicrobial Resistance in Staphylococcus (28 papers). Hideharu Hagiya collaborates with scholars based in Japan, United States and Myanmar. Hideharu Hagiya's co-authors include Fumio Otsuka, Yoshito Nishimura, Kazunori Tomono, Yukihiro Akeda, Hisao Yoshida, Toshihiro Koyama, Kazuki Tokumasu, Isao Nishi, Norihisa Yamamoto and Yuki Otsuka and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Hideharu Hagiya

270 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideharu Hagiya Japan 21 470 460 454 374 266 307 2.2k
Hyun‐Ha Chang South Korea 30 704 1.5× 768 1.7× 924 2.0× 323 0.9× 319 1.2× 117 2.4k
Ki Tae Kwon South Korea 29 1.1k 2.3× 1.0k 2.2× 791 1.7× 414 1.1× 185 0.7× 170 2.9k
Alessandro Russo Italy 29 810 1.7× 1.2k 2.5× 961 2.1× 150 0.4× 106 0.4× 136 2.9k
Ali M. Somily Saudi Arabia 22 286 0.6× 335 0.7× 635 1.4× 133 0.4× 86 0.3× 116 2.2k
Kayoko Hayakawa Japan 32 933 2.0× 765 1.7× 1.3k 2.9× 407 1.1× 276 1.0× 222 3.7k
Anders Boyd Netherlands 33 342 0.7× 1.7k 3.7× 1.0k 2.2× 220 0.6× 161 0.6× 229 3.8k
Sara Y. Tartof United States 30 261 0.6× 1.2k 2.5× 2.0k 4.5× 243 0.6× 550 2.1× 137 4.3k
Karim Manji Tanzania 32 240 0.5× 617 1.3× 754 1.7× 105 0.3× 91 0.3× 194 3.8k
Sarah Tschudin‐Sutter Switzerland 31 610 1.3× 1.1k 2.4× 1.5k 3.4× 207 0.6× 175 0.7× 153 3.3k
Giovanni Battista Orsi Italy 25 217 0.5× 338 0.7× 538 1.2× 97 0.3× 67 0.3× 80 2.2k

Countries citing papers authored by Hideharu Hagiya

Since Specialization
Citations

This map shows the geographic impact of Hideharu Hagiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideharu Hagiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideharu Hagiya more than expected).

Fields of papers citing papers by Hideharu Hagiya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideharu Hagiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideharu Hagiya. The network helps show where Hideharu Hagiya may publish in the future.

Co-authorship network of co-authors of Hideharu Hagiya

This figure shows the co-authorship network connecting the top 25 collaborators of Hideharu Hagiya. A scholar is included among the top collaborators of Hideharu Hagiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideharu Hagiya. Hideharu Hagiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishida, Clinton R., Hiroyuki Honda, Yuki Otsuka, et al.. (2025). Impact of Lifestyle Changes on Body Weight Gain During Nationwide Lockdown Due to COVID-19 Pandemic. Journal of Clinical Medicine. 14(7). 2242–2242. 1 indexed citations
2.
Hagiya, Hideharu, et al.. (2025). Intention and potential determinants of COVID-19 vaccination among healthcare workers at a single university hospital in Japan, 2024–2025 pre-season. Journal of Infection and Chemotherapy. 31(3). 102660–102660. 1 indexed citations
3.
Gotoh, Kazuyoshi, et al.. (2024). Genetic variability in Neisseria meningitidis strains isolated in a Japanese hospital. IJID Regions. 14. 100511–100511. 1 indexed citations
4.
Otsuka, Yuki, et al.. (2024). Prostate abscess caused by ESBL-producing Escherichia coli successfully treated with fosfomycin monotherapy. International Journal of Antimicrobial Agents. 63(6). 107182–107182. 1 indexed citations
5.
Otsuka, Yuki, et al.. (2024). Human Papillomavirus vaccination awareness and uptake among healthcare students in Japan. Journal of Infection and Chemotherapy. 31(2). 102554–102554. 2 indexed citations
7.
Ichihara, Eiki, Kou Hasegawa, Kenichiro Kudo, et al.. (2023). A randomized controlled trial of teprenone in terms of preventing worsening of COVID-19 infection. PLoS ONE. 18(10). e0287501–e0287501. 1 indexed citations
8.
Tokumasu, Kazuki, Naruhiko Sunada, Yasue Sakurada, et al.. (2023). Characteristics of Persistent Symptoms Manifested after SARS-CoV-2 Vaccination: An Observational Retrospective Study in a Specialized Clinic for Vaccination-Related Adverse Events. Vaccines. 11(11). 1661–1661. 3 indexed citations
9.
Hagiya, Hideharu, et al.. (2023). A case of typhoid fever presenting with non-G6PD associated Hemolytic anaemia. Journal of Travel Medicine. 30(6). 1 indexed citations
10.
Fujiwara, Tomohiro, Hiroyuki Yanai, & Hideharu Hagiya. (2023). Like a shot‐through manubrium: A rare presentation of skeletal tuberculosis. SHILAP Revista de lepidopterología. 11(5). e7119–e7119. 1 indexed citations
11.
Hagiya, Hideharu, Yuki Otsuka, & Fumio Otsuka. (2022). Call for correction: Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. Journal of the Neurological Sciences. 436. 120232–120232. 1 indexed citations
12.
Sakurada, Yasue, Naruhiko Sunada, Hiroyuki Honda, et al.. (2022). Serial Changes of Long COVID Symptoms and Clinical Utility of Serum Antibody Titers for Evaluation of Long COVID. Journal of Clinical Medicine. 11(5). 1309–1309. 20 indexed citations
13.
Tokumasu, Kazuki, Hiroyuki Honda, Naruhiko Sunada, et al.. (2022). Clinical Characteristics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Diagnosed in Patients with Long COVID. Medicina. 58(7). 850–850. 35 indexed citations
14.
Hagiya, Hideharu, et al.. (2022). Rhinogenic optic neuropathy with hemianopia caused by ethmoidal sinus mucocele. SHILAP Revista de lepidopterología. 10(12). e6696–e6696. 1 indexed citations
15.
Otsuka, Yuki, et al.. (2021). Barium appendicitis. SHILAP Revista de lepidopterología. 9(7). e04583–e04583. 1 indexed citations
16.
Fukuda, Naoko, et al.. (2021). Emphysematous gastritis. SHILAP Revista de lepidopterología. 9(11). e05094–e05094. 4 indexed citations
17.
Hagiya, Hideharu, et al.. (2021). Anti-Glomerular Basement Membrane Nephritis Potentially Induced by Nebulized Tobramycin Inhalation. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 35(2). 104–106.
18.
Nakamaru, Ryo, Kōichi Yamamoto, Satoko Nozato, et al.. (2019). A case of primary aldosteronism with resistant hypertension successfully treated by unilateral adrenalectomy after unsuccessful classification of subtype in adrenal venous sampling. SHILAP Revista de lepidopterología. 7(10). 1895–1899. 2 indexed citations
19.
Hagiya, Hideharu, Kotaro Aoki, Yukihiro Akeda, et al.. (2019). In Vitro Effectiveness of Meropenem and Cefmetazole Combination Treatment Against KPC-2-Producing Enterobacteriaceae. Microbial Drug Resistance. 25(6). 839–845. 10 indexed citations
20.
Kimura, Keigo, Hideharu Hagiya, Isao Nishi, Hisao Yoshida, & Kazunori Tomono. (2018). Roseomonas mucosa bacteremia in a neutropenic child: A case report and literature review. IDCases. 14. e00469–e00469. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026